Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance.

Saved in:
Bibliographic Details
Title: Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance.
Authors: Channathodiyil P; Epigenetics Programme, Babraham Institute, Cambridge, CB22 4NT, UK., May K; Epigenetics Programme, Babraham Institute, Cambridge, CB22 4NT, UK., Segonds-Pichon A; Babraham Bioinformatics, Babraham Institute, Cambridge, CB22 4NT, UK., Smith PD; Oncology R&D, AstraZeneca CRUK Cambridge Institute, Cambridge, CB2 0AA, UK., Cook SJ; Signalling Programme, Babraham Institute, Cambridge, CB22 4NT, UK., Houseley J; Epigenetics Programme, Babraham Institute, Cambridge, CB22 4NT, UK.
Source: NAR cancer [NAR Cancer] 2022 Oct 17; Vol. 4 (4), pp. zcac032. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-8674
DOI:10.1093/narcan/zcac032